![]() |
|
|
Vol. 298, Issue 1, 354-361, July 2001
Department of Physiology, Faculty of Medicine, Toyama Medical and
Pharmaceutical University, Toyama, Japan
(1R)-1-benzo [b]
thiophen-5-yl-2-[2-(diethylamino) ethoxy] ethan-1-ol hydrochloride
(T-588) is a compound for the treatment of neurodegenerative disorders,
including Alzheimer's disease and cerebrovascular diseases. T-588
reportedly alleviates learning and memory deficits in animal models of
dementia. In the present study, we investigated the effects of T-588 on
the induction and decay of long-term potentiation (LTP) and on the
responses to paired-pulse (pp) stimulation in freely moving rats.
Perforant path-evoked field potentials were recorded in the dentate
gyrus by chronically implanted electrodes. LTP was induced by
high-frequency stimulation 30 min after oral administration of T-588
(0.3 or 3 mg/kg). T-588 significantly augmented the increase in
population spike amplitude and field excitatory postsynaptic potential
slope after LTP induction. T-588 also prolonged the decay of augmented population spike amplitude, but had no significant effect on the response to pp stimulation. These results suggest that T-588
facilitates long-term synaptic plasticity, but not short-term synaptic
plasticity in the dentate gyrus of freely moving rats. The effect of
T-588 on long-term synaptic plasticity may contribute to the
alleviation of learning and memory dysfunction seen in animal models.